Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial

Journal:

Nature Medicine

Published:

2025-09-24

DOI:

10.1038/s41591-025-03937-8

Affiliations:

11

Authors:

22

Go to article

Institutions	Authors	Share
Zhejiang University Medical Center, China	8.000000	0.36
The First Affiliated Hospital, Zhejiang University School of Medicine, China	6.750000	0.31
Zhejiang University (ZJU), China	3.750000	0.17
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China	1.500000	0.07
Fudan University, China	0.500000	0.02
YaKe Biotech, China	0.500000	0.02
Affiliated Jinling Hospital, NJU, China	0.500000	0.02
Renji Hospital, SJTU, China	0.500000	0.02

Interested in Clinical Sciences?